CIK 0001754068
- Non-accelerated filer
- Smaller reporting company
Kalaris Therapeutics, Inc.
Sign in to watch- Ticker
- KLRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831971007
- Phone
- +1 650-249-2727
- Business address
- 400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Allovir, Inc., ViraCyte, Inc.
- 4 Open-market sale Chief Accounting Officer sold 554 shares at $0.55 ($304)
- 4 Open-market sale Sinha Vikas sold 3,186 shares at $0.55 ($1,748)
- 4 Open-market sale General Counsel sold 432 shares at $0.55 ($237)
- 4 Open-market sale Chief Executive Officer sold 8,706 shares at $0.55 ($4,775)
- 4 Open-market sale Chief Executive Officer sold 10,609 shares at $0.86 ($9,176)
- 4 Open-market sale General Counsel sold 2,272 shares at $0.86 ($1,965)
- 4 Open-market sale Chief Accounting Officer sold 1,655 shares at $0.86 ($1,431)
- 4 Open-market sale Sinha Vikas sold 5,136 shares at $0.86 ($4,442)
- 4 Open-market sale Sinha Vikas sold 3,428 shares at an average $0.77 ($2,649)
- 4 Open-market sale Chief Executive Officer sold 9,752 shares at $0.78 ($7,597)
- 4 Open-market sale Chief Accounting Officer sold 965 shares at an average $0.77 ($746)
- 4 Open-market sale General Counsel sold 1,401 shares at an average $0.77 ($1,083)
- 4 Open-market sale Sinha Vikas sold 940 shares at $0.81 ($766)
- 4 Open-market sale General Counsel sold 377 shares at $0.81 ($307)
- 4 Open-market sale Chief Executive Officer sold 1,493 shares at $0.81 ($1,216)
- 4 Open-market sale Chief Accounting Officer sold 301 shares at $0.81 ($245)
- 4 Open-market sale Chief Executive Officer sold 5,390 shares at $0.74 ($3,996)
- 4 Open-market sale General Counsel sold 422 shares at $0.76 ($321)
- 4 Open-market sale Chief Accounting Officer sold 544 shares at $0.76 ($413)
- 4 Open-market sale Sinha Vikas sold 3,159 shares at $0.76 ($2,399)
Page 4 of 19 · 363 filings